CinRx Pharma’s Post

View organization page for CinRx Pharma, graphic

2,063 followers

Concurrent with the initiation of our Phase 2 study of CIN-103 for the treatment of chronic #IrritableBowelSyndrome with predominant diarrhea (IBS-D), Dr. Darren Brenner, Professor of #Gastroenterology at Northwestern University, shared his thoughts on CIN-103's potential to address the unmet medical need for a long-term treatment of IBS-D. Learn more: https://bit.ly/48ug4QW

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics